APOE and Alzheimer disease: We have previously shown increased population of glial-derived EVs resulting from neuroinflammation in AD patients’ brains5,6,18, suggesting that molecular structures in AD BDEVs could be highly impacted by glial lipid dysmetabolism mediated by APOE4 genotype.